Study reading
We separate a study’s stated findings from broader claims that its design may not support, including questions about sample, methods, follow-up, and interpretation.
Independent information services
Services
Guides, comparisons, and research summaries from Magnesa on Stanford Ibogaine Study—built for people who need careful context before drawing conclusions from early evidence.
A clear remit
Information designed for difficult questions.
Magnesa is an independent resource on the Stanford-linked magnesium–ibogaine study and the evolving evidence around ibogaine. It helps veterans, families, researchers, policymakers, and others understand study design, limitations, safety concerns, and policy context.
Our work begins with the questions people bring to the Stanford Ibogaine Study overview: what was studied, what remains uncertain, and what should not be inferred from a single research result. The purpose is plain-language context, not a clinical recommendation or treatment referral.
Three standards behind every guide.
These information services are structured around the same commitments: independence, evidence before hype, plain language, safety context, and scientific humility.
Safety context
Ibogaine has significant safety considerations. The FDA’s drug development process illustrates why early research, safety assessment, and regulatory review are distinct stages rather than interchangeable signals of readiness.
Plain comparison
We identify differences in language, setting, and scope so readers can compare claims without mistaking marketing, anecdote, or policy debate for research evidence.
A record of restraint
Evidence is strongest when its limits remain visible.
Magnesa does not offer medical care, make treatment promises, or present itself as a clinic. Instead, our materials maintain a distinction between research findings, individual decisions, and the legal or medical questions that require qualified advice.
Independent resource standard
Each guide is framed to preserve uncertainty, identify safety relevance, and avoid treating preliminary results as settled conclusions.
Information offerings
Practical formats for reading research with care.
These are informational services: structured explanations, comparisons, and question sets intended to make complex material easier to examine without overstating what it can answer.
Research summaries
Concise study-focused guides clarify what a paper or project reports, the limits of its design, and the questions that should remain open. The principles behind Magnesa’s approach explain why uncertainty is included rather than edited away.
Decision frameworks
Comparison tools help readers identify meaningful differences between research, policy discussions, and treatment-related claims. A basic clinical trial framework is useful for understanding why outcomes, participants, and study controls matter when interpreting results.
Plain-language terms
Definitions reduce the risk that technical vocabulary carries more certainty than it deserves. For foundational treatment context, our guide to what an ibogaine treatment involves can help distinguish general descriptions from Stanford-linked study questions.
Safety and policy questions
Our FAQ collections organize recurring concerns around risk, ethics, and regulation. They are not a substitute for professional advice, particularly because the DEA’s ibogaine factsheet notes its controlled-substance status in the United States.
A consistent method
How the material is organized.
Magnesa structures each resource so readers can locate the central claim, the underlying evidence, the safety context, and the unanswered questions without confusing one category for another.
- 01Start with the question. Identify whether the material concerns research, policy, safety, costs, or a provider’s own description.
- 02Locate the evidence. Note what was measured, who was included, and what a result can—and cannot—establish.
- 03Keep safety in view. Treatment cost and availability do not resolve risk. Context on the cost of ibogaine treatment belongs alongside, not ahead of, questions about safety and evidence.
- 04Separate source from inference. Historical or botanical background, including information about ibogaine plants, may be relevant context but is not proof of clinical benefit.
Common questions
What these services are—and are not.
The short answers below describe Magnesa’s role as an independent information resource.
Are these medical or treatment services?
No. Magnesa provides independent informational guides, comparisons, research summaries, and safety context. It is not a clinic, medical provider, or licensed treatment center.
Can a guide determine whether ibogaine is appropriate for someone?
No. A guide can explain evidence and uncertainty, but it cannot assess an individual situation. Discussions of facilities, including an ibogaine clinic in Mexico, should not be confused with a recommendation, referral, or individualized medical guidance.
What does Magnesa cover?
Magnesa covers study design, limitations, safety concerns, policy context, and the evolving evidence around Stanford-linked magnesium–ibogaine research. The scope remains informational, evidence-first, and careful about uncertainty and risk.
An independent resource
Keep the question larger than the claim.
Magnesa exists to support careful reading of Stanford-linked ibogaine research and the surrounding public discussion. For a fuller picture of the resource’s purpose, standards, and limits, visit the Magnesa mission and methodology.
Contact context